Citi initiates coverage on Ategrity Specialty Insurance stock with Neutral rating

Published 07/07/2025, 12:44
Citi initiates coverage on Ategrity Specialty Insurance stock with Neutral rating

Investing.com - Citi has initiated coverage on Ategrity Specialty Insurance (NYSE:ASIC), a specialty insurance provider with a market capitalization of approximately $995 million, with a Neutral rating and a $26.00 price target, implying a potential total return of approximately 23%. The company’s stock currently trades at $21.13, near its 52-week low of $20.20.

The research firm classified the rating as "Neutral/High Risk" in its initial assessment of the specialty insurance provider, suggesting a balanced risk-reward profile at current levels. InvestingPro data reveals the company maintains strong liquidity with a current ratio of 1.53, though it currently shows weak gross profit margins of about 20%.

Citi noted that Ategrity’s fundamentals appear strong enough to support the company’s growth plans through at least 2026, providing a foundation for its business expansion strategy.

The firm indicated that Ategrity needs to demonstrate genuine underwriting competency to receive credit for its growth trajectory, highlighting this as a key factor for future valuation.

Citi cautioned that while no negative developments are expected in the near term, it could take up to 24 months to properly evaluate Ategrity’s risk selection and pricing capabilities.

In other recent news, Ategrity Specialty Insurance has made significant strides with its initial public offering on the New York Stock Exchange. The company began trading at $23.65 per share after setting its IPO price at $17.00, expected to raise $113.3 million in gross proceeds. Barclays (LON:BARC) initiated coverage on Ategrity with an Overweight rating and a price target of $30.00, citing the company’s growth potential and expected improvements in return on equity. Barclays forecasts a substantial increase in Ategrity’s gross written premium growth over the next few years. Similarly, JPMorgan also started coverage with an Overweight rating, setting a price target of $26.00 for December 2026. While acknowledging some risks, JPMorgan expressed confidence in the company’s management and business plan, suggesting the stock is undervalued. Both firms view Ategrity’s focus on the small commercial segment within the excess and surplus lines market as a strong point.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.